Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesche Tallen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
FEBS Letters|January 17, 2017
DisorderING promotes epigenetic orderGesche Tallen, Karl Riabowol
FEBS Letters|March 18, 2014
Keep-ING balance: tumor suppression by epigenetic regulationGesche Tallen, Karl Riabowol
Pharmazie in Unserer Zeit|July 31, 2012
[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing]Gesche Tallen, Günter Henze, Arend von Stackelberg
Rejuvenation Research|August 22, 2007
The cancer-aging interface and the significance of telomere dynamics in cancer therapyGesche Tallen, Mohamed A Soliman, Karl Riabowol
Endocrine Pathology|May 7, 2020
DNA measurement, proliferation markers, and other factors in pituitary adenomasAngelika Krämer, Wolfgang Saeger, Gesche Tallen, et al.
Molecular Cancer Therapeutics|January 28, 2010
Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylationBrigitte Sinn, Gesche Tallen, Gisela Schroeder, et al.
International Journal of Cancer|September 24, 2004
Pdgfr-alpha in 1p/19q LOH oligodendrogliomasChristian Hartmann, Xiudan Xu, Gesine Bartels, et al.
International Journal of Cancer|February 13, 2004
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytomaGesche Tallen, Ines Kaiser, Sonja Krabbe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2010
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study GroupArend von Stackelberg, Enrico Völzke, Jörn-Sven Kühl, et al.
Oncology Research|August 5, 2010
The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cellsMona Tamannai, Sonja Farhangi, Matthias Truss, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
FEBS Letters|January 17, 2017
DisorderING promotes epigenetic orderGesche Tallen, Karl Riabowol
FEBS Letters|March 18, 2014
Keep-ING balance: tumor suppression by epigenetic regulationGesche Tallen, Karl Riabowol
Pharmazie in Unserer Zeit|July 31, 2012
[Treatment of children and adolescents with relapsed ALL: therapy target long-term healing]Gesche Tallen, Günter Henze, Arend von Stackelberg
Rejuvenation Research|August 22, 2007
The cancer-aging interface and the significance of telomere dynamics in cancer therapyGesche Tallen, Mohamed A Soliman, Karl Riabowol
Endocrine Pathology|May 7, 2020
DNA measurement, proliferation markers, and other factors in pituitary adenomasAngelika Krämer, Wolfgang Saeger, Gesche Tallen, et al.
Molecular Cancer Therapeutics|January 28, 2010
Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylationBrigitte Sinn, Gesche Tallen, Gisela Schroeder, et al.
International Journal of Cancer|September 24, 2004
Pdgfr-alpha in 1p/19q LOH oligodendrogliomasChristian Hartmann, Xiudan Xu, Gesine Bartels, et al.
International Journal of Cancer|February 13, 2004
No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytomaGesche Tallen, Ines Kaiser, Sonja Krabbe, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2010
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study GroupArend von Stackelberg, Enrico Völzke, Jörn-Sven Kühl, et al.
Oncology Research|August 5, 2010
The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cellsMona Tamannai, Sonja Farhangi, Matthias Truss, et al.
Pageof 2